Aristotle University Of Thessaloniki (AUTH)
Προγνωστικοί δείκτες και έκβαση σε αρρώστους υποβληθέντες σε αορτοστεφανιαία παράκαμψη με χρήση μόνον αρτηριακών μοσχευμάτων
Abstract
dc:descriptionABSTRACT. Ischaemic heart disease is a leading cause of death worldwide and constitutes a major medical and socioeconomic problem. Coronary artery bypass grafting relieves symptoms and improves survival in patients with severe coronary artery disease. The main prognostic benefit derives from the use of the left internal mammary artery (LIMA) grafted to the native left anterior descending branch (LAD). Large series and meta-analyses showed that total arterial revascularization (TAR) may offer additional survival benefit. The primary aim of this study is to investigate long-term (> 5 years) survival of patients undergoing total arterial revascularization. The secondary objective is the evaluation of potential change in coronary artery disease main risk factors during the period of follow-up.Methods: The population studied consisted of 40 patients undergoing coronary artery bypass grafting (CABG) with total arterial revascularization (TAR). All patients were screened for coronary artery disease risk factors. Repeat coronary angiography at a 5-year follow-up was used to investigate the long-term patency of arterial grafts.Results: Mean EuroSCORE was 1.42±1.1%. Mean follow-up time was 9.3±4.8 years (range: one month to 15.6 years). The 30-day mortality was 2.5% (1/40 patients), while the 12-month mortality was 7.5% (3/40 patients) with an actual survival of 92.5%. The 5-year and 10-year mortality was 15.8% (6/38 patients) and 33.3% (10/30 patients) respectively, while actual survival reached 84.2% and 66.7% at 5 and 10 years respectively. A total of 10/40 patients (25%) died during follow-up. Mean time-to-event was 3.5±2.7 years (range: one month to 7.1 years). 40% of deaths occurred during the first 2 years from the procedure, while a similar proportion (40%) was observed during the period from 4.5 to 6.5 years post-surgery. The main cause of death was cerebrovascular disease in 30% of patients, while 20% died of cancer. 40% of deaths were cardiac-related but not due to ischemic heart disease. The use of the radial artery resulted in a similar survival to the use of bilateral internal mammary arteries exclusively. The incidence of major adverse cardiac and cerebrovascular events (a composite outcome of cardiac-related death, myocardial infarction, need for revascularization and stroke) was 17.5% during follow-up. Total morbidity reached 30%. Repeat coronary angiography at 5-year follow-up revealed that all arterial grafts were patent. Regarding coronary artery disease risk factors, incidence of smoking was statistically significantly reduced from 32.5% to 5% postoperatively (p<0,01). Moreover 40% of the study population achieved target values for the control of dislipidaemia (total cholesterol, LDL and HDL cholesterol, and triglycerides). Blood glucose levels were within normal limits in about two thirds of the diabetic patients. Control of arterial hypertension (blood pressure < 130/80 mmHg) was achieved in 65% of patients postoperatively compared to 22,5% preoperatively (p=0,01).Conclusions: Total arterial revascularization is safe and effective with encouraging results in terms of long-term survival. This is the first reported study investigating long-term outcome in patients undergoing total arterial revascularization in Greece. Larger multi-centre randomized studies are considered mandatory to reach final and indisputable conclusions.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tasoulas (Tassoulas), Ilias (Elias)
- Τασούλας, Ηλίας
Subjects
dc:subject × 12- Ισχαιμική καρδιοπάθεια
- Επεμβάσεις αορτοστεφανιαίας παράκαμψης
- Ολική αρτηριακή επαναιμάτωση
- Αρτηριακά μοσχεύματα
- Ishaemic Heart Disease (IHD)
- Coronary artery bypass graft surgery (CABG)
- Total arterial revascularization (TAR)
- Arterial grafts
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40421